Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|February 18, 2005
Greater than the sum of its parts: combining models for useful ADMET predictionSean E O'Brien, Marcel J de Groot
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 28, 2020
Pharmacokinetic and Pharmacodynamic Comparison of Intravenous and Inhaled CaspofunginIching G Yu, Sean E O'Brien, David M Ryckman
Journal of Molecular Graphics & Modelling|September 20, 2005
Computational tools for the analysis and visualization of multiple protein-ligand complexesSean E O'Brien, David G Brown, James E Mills, et al.
Drug Discovery Today|September 3, 2013
Targeting the nucleolus for cancer-specific activation of p53Denis Drygin, Sean E O'Brien, Ross D Hannan, et al.
Plos One|November 13, 2012
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cellsSofia Zanin, Christian Borgo, Cristina Girardi, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2012
Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cellsFabrice Pierre, Collin F Regan, Marie-Claire Chevrel, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2011
7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activityFabrice Pierre, Eric Stefan, Anne-Sophie Nédellec, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral propertiesFabrice Pierre, Sean E O'Brien, Mustapha Haddach, et al.
Pageof 2